These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1925593)

  • 21. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication.
    Allen TM; Mortara L; Mothé BR; Liebl M; Jing P; Calore B; Piekarczyk M; Ruddersdorf R; O'Connor DH; Wang X; Wang C; Allison DB; Altman JD; Sette A; Desrosiers RC; Sutter G; Watkins DI
    J Virol; 2002 Apr; 76(8):4108-12. PubMed ID: 11907251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS vaccines: is older better?
    Cohen J
    Science; 1992 Dec; 258(5090):1880-1. PubMed ID: 1470911
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel adjuvant strategies for experimental malaria and AIDS vaccines.
    Alving CR; Detrick B; Richards RL; Lewis MG; Shafferman A; Eddy GA
    Ann N Y Acad Sci; 1993 Aug; 690():265-75. PubMed ID: 8368743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus.
    Cranage MP; Baskerville A; Ashworth LA; Dennis M; Cook N; Sharpe S; Farrar G; Rose J; Kitchin PA; Greenaway PJ
    Lancet; 1992 Feb; 339(8788):273-4. PubMed ID: 1346285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of a major histocompatibility complex class I restricting simian immunodeficiency virus Gag241-249 epitope.
    Tsukamoto T; Dohki S; Ueno T; Kawada M; Takeda A; Yasunami M; Naruse T; Kimura A; Takiguchi M; Matano T
    AIDS; 2008 May; 22(8):993-4. PubMed ID: 18453861
    [No Abstract]   [Full Text] [Related]  

  • 30. Aids vaccine advance.
    Novak K; MacFarlane J; Aamodt S
    Nat Med; 2000 Nov; 6(11):1220. PubMed ID: 11062531
    [No Abstract]   [Full Text] [Related]  

  • 31. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
    Yao WR; Li D; Yu L; Wang FJ; Xing H; Yang GB
    Immunol Res; 2017 Aug; 65(4):869-879. PubMed ID: 28478499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDS vaccine research. A new goal: preventing disease, not infection.
    Cohen J
    Science; 1993 Dec; 262(5141):1820-1. PubMed ID: 8266069
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunodeficiency viruses and nonhuman primate models of AIDS].
    Klots IN
    Vopr Virusol; 2009; 54(3):8-12. PubMed ID: 19537090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 neutralizing antibodies: how full is the bottle?
    Moore JP; Burton DR
    Nat Med; 1999 Feb; 5(2):142-4. PubMed ID: 9930854
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
    Voronin Y; Phogat S
    Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "The Duesberg phenomenon": Duesberg and other voices.
    Plotkin SA
    Science; 1995 Jan; 267(5196):315-6. PubMed ID: 7880305
    [No Abstract]   [Full Text] [Related]  

  • 38. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Conference on Advances in AIDS Vaccine Development.
    Snow W
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1433-4. PubMed ID: 1466975
    [No Abstract]   [Full Text] [Related]  

  • 40. An immuno-logic hypothesis.
    Kohler H; Muller S
    J Med Primatol; 2002 Aug; 31(4-5):311-2. PubMed ID: 12390548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.